Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus.
F
F
Laguna
J
J
Torre-Cisneros
V
V
Moreno
J L
JL
Villanueva
E
E
Valencia
D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000188:drug therapy*; D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004337:Drug Carriers; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy*; D008081:Liposomes
D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B